PEB - Pacific Edge Ltd

[NT001]

The trading halt late last week on Aussie cancer biotech company Cellmid, with which PEB has a working relationship, appears to have been for two reasons. Firstly, Cellmid has raised A$1.3m in new capital from selected investors to fund ongoing research including human clinical trials for an anti-cancer antibody.

And secondly, Cellmid has announced the securing of an important Japanese patent relating to an antibody for the cancer biomarker Midkine. PEB uses Midkine as a cancer biomarker in Cxbladder, under licence from Cellmid. Recent research indicates that targeting markers like Midkine with antibodies, such as are being developed by Cellmid, provides a promising new approach to curing cancer and certain autoimmune diseases.

[Minerbarejet]

Edison report out again , up to 1.16

Roflmao , get a proofreader Edison.

An L missing in Public Healthcare.

[Dentie]

Interesting their valuation only appears to include CxBladder...

[Baa_Baa]

Is this the Edison report .. "On the edge of glory"

? dated 29 Sept .. ?
http://www.edisoninvestmentresearch..../pacific-edge1

[slack]

The new report is here:
http://www.edisoninvestmentresearch....1214update.pdf

Perhaps there's some other way to find them when they're released but they're listed here:
https://www.nzx.com/markets/NZSX/sec...s/PEB/analysis

[Minerbarejet]

I have a google alert set up with the words Pacific Edge and another with CxBladder which seems to do the trick.

[Baa_Baa]

The new report is here:
http://www.edisoninvestmentresearch....1214update.pdf

Perhaps there's some other way to find them when they're released but they're listed here:
https://www.nzx.com/markets/NZSX/sec...s/PEB/analysis

Thanks. Interesting that their Sept update said "We value Pacific Edge at NZ$1.16 per share." and now their latest update "we increase our fair value to NZ$369m from NZ$338m (NZ$1.16 per share from NZ$1.06)" Something odd there, nevertheless, from $0.83 today, $1.16 is almost 40% upside.

[winner69]

Thanks. Interesting that their Sept update said "We value Pacific Edge at NZ$1.16 per share." and now their latest update "we increase our fair value to NZ$369m from NZ$338m (NZ$1.16 per share from NZ$1.06)" Something odd there, nevertheless, from $0.83 today, $1.16 is almost 40% upside.

Think they had the wrong number of shares in the original Sept report when they said $1.16...or something like that

[Minerbarejet]

Edison forgot to include the capital raising of last year which diluted about 11% from 116 to 106. That was corrected and a new report was issued with 1.06 as the valuation.
Now we have a new valuation which, coincidentally, puts it back to 116.
Wonder what Forbarr will come up with.

[Baa_Baa]

Edison forgot to include the capital raising of last year which diluted about 11% from 116 to 106

Well that inspires confidence in their analysis! Not.